anyone prepared to have a guess at the half yearly financials? Here are some numbers I made up.
EXECUTIVE SUMMARYResults: Half Year to 31 December 2024
- Revenues up 6%
- Net assets increased 7%; cash and term deposits up 8% from 30 June 2023 to $198m
- NPBT $14.8m, unchanged
- NPAT $10m,
- All figures reported in Australian dollars, $
31 December 24
31 December 2023
31 December 2022
Change
1 Revenues, $
34,000,000
32,256,885
29,355,042
6%
2 Expenses, $
23,000,000
20,924,198
16,376,227
10%
3 Net Profit before tax, $
14,800,000
14,805,699
14,599,951
0%
4 Net Profit after tax, $
10,000,000
10,936,043
11,387,665
-4.0%
5 Basic earnings per share, $
0.21
0.22
0.23
-3.9%
6 Cash and term deposits, $
198,000,000
174,449,193
156,813,537*
+11.2%*
- Forums
- ASX - By Stock
- CUV
- Ann: Change in substantial holding
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.89%
!
$10.26

Ann: Change in substantial holding, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.26 |
Change
0.190(1.89%) |
Mkt cap ! $512.7M |
Open | High | Low | Value | Volume |
$10.15 | $10.50 | $10.09 | $335.7K | 32.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | $10.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.28 | 317 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 416 | 10.250 |
2 | 206 | 10.240 |
2 | 205 | 10.230 |
2 | 207 | 10.220 |
5 | 939 | 10.210 |
Price($) | Vol. | No. |
---|---|---|
10.290 | 19 | 4 |
10.300 | 143 | 3 |
10.310 | 109 | 2 |
10.320 | 1087 | 5 |
10.330 | 2109 | 3 |
Last trade - 12.45pm 26/06/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online